Drugs / Personalized mature dendritic cell vaccine
last change Oct 2023 re-read 2 minutes ago

Personalized mature dendritic cell vaccine

Vaccine

Developed for
non-small cell lung carcinoma
Investigated by
Washington University School of Medicine

Trials 1 · a red edge is where a trial was stopped

2017201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT02419170 Jul 2016 → Oct 2019 non-small cell lung carcinoma Washington University School of Medicine Withdrawn No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Personalized mature dendritic cell vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT02419170
Modality Vaccine “personalized dendritic cell vaccineNCT02419170